NEW YORK Three distinguished Columbia University Medical Center faculty have been elected to the Institute of Medicine of the National Academy of Sciences this year.
Election to the Institute of Medicine (IOM) is one of the highest honors in the fields of medicine and health, and Columbia now has 49 members in this esteemed organization. The three CUMC faculty Kathryn Calame, Timothy Pedley and Carolyn Westhoff were among the 65 new IOM members announced Oct. 8, 2007, raising its total active IOM membership to 1,538.
Columbias new members were chosen through a highly selective process that recognizes individuals who have made significant contributions to advancing the medical science, health care, and public health fields, said Lee Goldman, M.D., executive vice president for health and biomedical sciences and dean of the faculties of health and medicine at Columbia University. We are proud to have them in our midst.
Kathryn Calame, Ph.D., is professor of microbiology and of biochemistry & molecular biophysics at Columbias College of Physicians and Surgeons. Dr. Calame studies gene regulation in the immune system, and her laboratory work focuses primarily on transcriptional regulation of lymphocyte development. A major focus of her current work is an unusual transcriptional repressor called Blimp-1 (B lymphocyte induced maturation protein). Her studies on Blimp-1 are revealing important aspects of regulation in both B and T cells.
Timothy A. Pedley, M.D., is the Henry and Lucy Moses Professor of Neurology, chairman of the Department of Neurology at P&S, and neurologist-in-chief at the Neurological Institute at New York-Presbyterian Hospital. Dr. Pedleys clinical and research interests are focused on epilepsy. His laboratory interests are in the role played by the ionic microenvironment in abnormal hippocampal and cortical excitability and in long-lasting changes in the hippocampus induced by repeated seizures.
Carolyn L. Westhoff, M.D., is professor of obstetrics and gynecology at P&S and professor of epidemiology and of population and family health at Columbias Mailman School of Public Health. She studies the effect of obesity on contraceptive effectiveness and leads several research projects investigating contraception and the epidemiology of womens reproductive health. Most recently, Dr. Westhoff was the principal investigator of a clinical trial of a novel oral contraceptive initiation method known as Quick Start.
|Contact: Alex Lyda|
Columbia University Medical Center